Stay updated on Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.

Latest updates to the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page
- Check4 days agoChange DetectedAdded a new revision entry (v3.3.2) and removed the previous entry (v3.3.1) in the page's version history, affecting only metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoChange DetectedThe record history now includes a new revision entry v3.3.1 and removes v3.2.0, reflecting metadata updates in the history rather than changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the government funding and operating status disclaimer from the page; the remaining study record content and history are unchanged.SummaryDifference0.6%

- Check33 days agoChange DetectedThe new screenshot shows an extra version entry in the record history and minor formatting changes to the page.SummaryDifference0.1%

- Check62 days agoChange DetectedUpdate includes a critical operating-status notice and a new software version (v3.2.0) replacing the previous v3.1.0.SummaryDifference11%

- Check69 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.